Telo Genomics Corp.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
87975M208
SEDOL
N/A
CIK
N/A
www.telodx.com
LEI:
©
New: Infographics X-Lab
FIGI: BBG0025YXN26
TDSGF
Telo Genomics Corp.
GICS: - · Sektor: Healthcare · Sub-Sektor: Diagnostics & Research
AI
PROFILER
NAME
Telo Genomics Corp.
ISIN
CA87975M2085
TICKER
TDSGF
MIC
XOTC
REUTERS
TDSGF.PK
BLOOMBERG
TDSGF US
F&G: 75
1,36918 USDCAD · 118.810,91 BTC · 17,28 Vola-Index · 22.773,43 Tech100
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von Newsfile Corp. bereitgestellt.
Di., 01.07.2025       Telo Genomics
CA87975M2085

Toronto, Ontario--(Newsfile Corp. - June 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") has received a Statement of Claim filed by Sherif Louis, the former President of the Company, in the amount of approximately $530,000 for notice and bonuses that he claims are owed to him. Telo intends to file a st...
Zur Nachricht
Telo Genomics
Technische Analyse Termsheet Terminal
Permalink
Mi., 18.06.2025       Telo Genomics
CA87975M2085

Toronto, Ontario--(Newsfile Corp. - June 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human disease through its proprietary 3D analysis of the genomic instability of telomeres, is pleased to announce that it has initiated a multiple myeloma ...
Zur Nachricht
Telo Genomics
Technische Analyse Termsheet Terminal
Permalink
Di., 27.05.2025       Telo Genomics
CA87975M2085

Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of telomeres, is pleased to announce that it has entered a new client agreement with Intellectual Property Ontario (IPON)....
Zur Nachricht
Telo Genomics
Technische Analyse Termsheet Terminal
Permalink
Do., 15.05.2025       Telo Genomics
CA87975M2085

Toronto, Ontario--(Newsfile Corp. - May 15, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal telomeres, today announced that the European Hematology Association ("EHA") has accepted Telo Genomics' abs...
Zur Nachricht
Telo Genomics
Technische Analyse Termsheet Terminal
Permalink
Do., 10.04.2025       Telo Genomics
CA87975M2085

Toronto, Ontario--(Newsfile Corp. - April 10, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal telomeres, today announced that the American Society of Clinical Oncology (ASCO) has accepted Telo Genom...
Zur Nachricht
Telo Genomics
Technische Analyse Termsheet Terminal
Permalink
Fr., 04.04.2025       Telo Genomics
CA87975M2085

Toronto, Ontario--(Newsfile Corp. - April 4, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal telomeres, is pleased to announce that John Farlinger has joined the Company's Board of Directors...
Zur Nachricht
Telo Genomics
Technische Analyse Termsheet Terminal
Permalink
Mi., 12.03.2025       Telo Genomics
CA87975M2085

Toronto, Ontario--(Newsfile Corp. - March 12, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal telomeres, is pleased to announce Mr. Guido Baechler, has assumed the role of Executive Chairman...
Zur Nachricht
Telo Genomics
Technische Analyse Termsheet Terminal
Permalink
Do., 27.02.2025       Telo Genomics
CA87975M2085

Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") announces that, further to its engagement with Trusted Health Advisors ("THA"), as disclosed in a news release dated January 30, 2024, the Company has expanded and extended its agreement (the "Agreement") with ...
Zur Nachricht
Telo Genomics
Technische Analyse Termsheet Terminal
Permalink
Mo., 23.12.2024       Telo Genomics
CA87975M2085

Toronto, Ontario--(Newsfile Corp. - December 23, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA) (the "Company" or "Telo") is pleased to announce that, further to its news release dated December 12, 2024, it has closed an over-subscribed, non-brokered private placement of 25,459,000 units ("Units") at a price of $0.10 per Unit f...
Zur Nachricht
Telo Genomics
Technische Analyse Termsheet Terminal
Permalink
Do., 12.12.2024       Telo Genomics
CA87975M2085

Toronto, Ontario--(Newsfile Corp. - December 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA) (the "Company" or "Telo") is pleased to announce a non-brokered private placement of units ("Units") at a price of $0.10 per Unit for gross proceeds of up to $2,000,000 (the "Offering").Each Unit will consist of one common share of t...
Zur Nachricht
Telo Genomics
Technische Analyse Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

BARRISTA SMART * AD

P R O D U C T   S U G G E S T I O N S